
Flora de Pablo
1952 · Spanish physician and cell and molecular biologist
Flora de Pablo Dávila (born in Salamanca, 1952) is a Spanish physician whose work focuses on cell and molecular biology, particularly how the nervous system forms during embryonic development and which growth factors guide that process.
She graduated in medicine in 1975 from the University of Salamanca, where she also studied psychology. Between 1976 and 1979 she worked as a resident medical intern and predoctoral researcher in the endocrinology service of the university's clinical hospital, earning her doctorate in internal medicine and endocrinology, the branch that studies hormones. She then spent about a decade in the United States, at the National Institutes of Health in Bethesda and at the California Institute of Technology (Caltech), with an intermediate period at the Hospital de la Santa Cruz y San Pablo in Barcelona.
In 1991 she returned to Spain as a researcher at the Center of Biological Research of the Spanish National Research Council (CSIC) in Madrid, where she founded a group devoted to growth factors in vertebrate development. Her team studies the role of proinsulin and insulin in the formation of the central nervous system and has explored possible biomedical applications in degenerative diseases, including retinal disorders and, more recently, Alzheimer's disease. In 2007 she co-founded Proretina Therapeutics, a company that aimed to develop a potential clinical therapy but closed in 2018 because it could not attract investors.
She directed the Instituto de Salud Carlos III between 2007 and 2008 and was the first president of the Association of Women Researchers and Technologists. Her legacy includes more than 140 research articles and a sustained public concern about the low representation of women in scientific decision-making.
Contributions
- Proinsulin and insulin in development Her work explored the role of these molecules in forming the central nervous system.
- Models of nerve degeneration Her group proposed translating its observations into biomedical applications for retinal diseases and Alzheimer's.
- Advocacy for gender equality in science She has publicly criticised the lack of recognition and representation of women researchers.
- Proretina Therapeutics She co-founded this technology company to develop a potential clinical therapy.
Sources
Original Medicapedia text based on:
Last updated: 5 November 2026 · How Medicapedia is made
A project by Alejandro Rosàs Navarro, family physician and specialist in preventive medicine and public health. Spotted a mistake? Write to info@medicapedia.org.